Zimmer Biomet Holdings, Inc. (NYSE:ZBH) enjoyed a 23.4% run-up in share price since hitting record low of $96.99. The stock managed -4.64% fall and now stands at $119.69 as of 4/17/2019. At a recent session, the prices were hovering between $119.01 and $125.84. This company shares are 10.08% off its target price of $131.75 and the current market capitalization stands at $24.43B. The recent change has given its price a -4.1% deficit over SMA 50 and -11.04% deficit over its 52-week high. The stock witnessed -4.8% declines, 13.99% gains and -3.09% declines for the 1-month, 3-month and 6-month period, respectively. To measure price-variation, we found ZBH’s volatility during a week at 2.47% and during a month it has been found around 1.69%.Zimmer Biomet Holdings, Inc. (ZBH) Top Holders
Institutional investors currently hold around $23.19 billion or 91.8% in ZBH stock. Look at its top three institutional owners: Blackrock Inc. owns $2 billion in Zimmer Biomet Holdings, Inc., which represents roughly 8.2% of the company’s market cap and approximately 8.64% of the institutional ownership. Similar statistics are true for the second largest owner, Vanguard Group Inc, which owns 15,041,869 shares of the stock are valued at $1.89 billion. The third largest holder is Massachusetts Financial Services Co /Ma/, which currently holds $1.71 billion worth of this stock and that ownership represents nearly 6.98% of its market capitalization.
At the end of December reporting period, 359 institutional holders increased their position in Zimmer Biomet Holdings, Inc. (NYSE:ZBH) by some 15,160,737 shares, 432 decreased positions by 12,935,551 and 183 held positions by 156,624,759. That puts total institutional holdings at 184,721,047 shares, according to SEC filings. The stock grabbed 97 new institutional investments totaling 1,015,757 shares while 102 institutional investors sold out their entire positions totaling 3,437,941 shares.Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Insider Trades
Multiple company employees have indulged in significant insider trading. Zimmer Biomet Holdings, Inc. disclosed in a document filed with the US Securities and Exchange Commission (SEC) that Director Jafry Syed A. has acquired 1,925 shares of Zimmer Biomet Holdings, Inc. (ZBH) in the trading session dated Mar. 01, 2019. These shares are worth $241,626 and were traded at $125.52 each. The SEC filing shows that HIGGINS ARTHUR J performed a purchase of 500 shares. The Director added these shares by way of transaction on Feb. 15, 2019. The company’s shares were assimilated at $123.28 per share worth to an investment of some $61,640 to the account of HIGGINS ARTHUR J.
Director, Farrell Michael J., purchased 2,000 common shares of Zimmer Biomet Holdings, Inc. (ZBH) in the open market. In a transaction dated Feb. 13, 2019, the shares were bought at an average price of $123.62, giving away a sum of $247,240. After this purchase, 2,000 common shares of ZBH are directly owned by the insider, with total stake valued at $239,380.
In the transaction dated Feb. 08, 2019, a great number of shares acquired came courtesy the Director; GLASSCOCK LARRY C added a total of 2,000 shares at an average price of $120.09, amounting to approximately $240,180. The insider now directly owns 8,633 shares worth $1,033,284.
Several analysts have released their opinion on Zimmer Biomet Holdings, Inc. (NYSE:ZBH), with 9 analysts believing it is a strong buy. Whereas 10 of them predict the stock is a hold. Also, there are 9 buy, 3 sell and 0 strong sell ratings, collectively assigning a 2.23 average brokerage recommendation [T1].